Flurazepam hydrochloride

This classification denotes a benzodiazepine with the molecular formula C21H23ClFN3O.2ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 756RDM536M, chemically known as 7-chloro-1-(2-(diethylamino)ethyl)-5-(2-fluorophenyl)-1h-1,4-benzodiazepin-2(3h)-one but more generally known as flurazepam dihydrochloride, which bears US NIH Compound Identifier 3393. European Medicines Agency schedules Flurazepam hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02238MIG. Most nations, for tariff and trade purposes, schedule flurazepam hydrochloride under HS 29339190 and SITC 51577. As of Q4 2014, FLURAZEPAM HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Flurazepam hydrochloride bears US NLM identifiers UMLS ID C0242293 and NCI Concept Code C29060. SMILES: CCN(CC)CCN1C2CCC(CC2C(=NCC1=O)C3CCCCC3F)CL.CL.CL.